Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn about a recent article by Nadira Frescalinea et al, published in The Lancet:
”Blood is not just a medical resource.
It’s infrastructure. It’s strategy. It’s sovereignty.
The warning from the NATO Blood Panel (via AABB, The Lancet) is clear:
The system won’t hold under real surge conditions.
- Reality
- 42-day shelf life
- Cold chain dependency
- Fragile logistics
Works in hospitals. Fails in disruption.
- Where it matters most
- Pre-hospital
- Battlefield
- Accidents
- Early transfusion equals survival
The gap:
It’s not donors.
It’s function delivery under pressure.
BHOC – what we believe
BHOC – Biological Hemoglobin Oxygen Carrier can fill the gap:
- Restore blood oxygenation immediately
- Controlled oxygen delivery
- Low-risk side effects
- No blood typing, no cold chain
- Rapid deployment where it matters most
Early oxygen delivery saves lives.
Top of that
What’s your opinion why we transfuse blood ?
What we treat ? How we define needs and outcome ?
Drop your idea, thought , share your opinion”
Title: Call to enhance civilian and military blood preparedness
Authors: Nadira Frescalinea, Andrew Beckett, Michael C Reade
Read the Full Article on The Lancet
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children